Patent ID: 6204266
Filing Date: 2001-03-20
Classification: A61K,A61P

Abstract:
A method for treating inflammation or cancer sensitive to the compounds below in a recipient in need thereof, comprising administering a pyrazine derivative of formula I or II to the recipient in an amount effective to exhibit an antioxidant effect in the recipient, wherein formula I has the following structures: ##STR4##wherein B is a radical selected from the group consisting of X, X-SO.sub.3 H, X-PO.sub.4 and X-alkyl.dbd.O in which X is an element selected from the group consisting of O, S, Se and Te; and R.sup.1 is H, R.sup.2 is selected from the group consisting of methyl, phenyl, p-hydroxybenzyl, and benzyl, R.sup.3 is p-hydroxyphenyl or p-methoxyphenyl and R.sup.4 is benzyl and substituted radicals of the foregoing.